A collaboration between 34 researchers at 18 institutions has looked into the efficacy and safety of psilocybin in patients with major depressive disorder.
High doses of psilocybin—the active ingredient in magic mushrooms—appears to have a similar effect on depressive symptoms as the selective serotonin reuptake inhibitor (SSRI) drug escitalopram, suggests a systematic review ...
Aug 21, 2024
0
69
People who consume psilocybin-containing mushrooms—otherwise known as magic mushrooms—typically undergo a surreal experience in which their sense of space, time and self is distorted. Advocates have long argued that, ...
Jul 17, 2024
0
121
Characterized by pathological weight loss driven by restrictive feeding and excessive exercise behaviors, anorexia nervosa (AN) has one of the highest mortality rates of any psychiatric disease.
May 13, 2024
0
114
Psilocybin—the active ingredient in "magic" mushrooms—is a more effective treatment for symptoms of depression than controls, providing further support for its potential as an antidepressant, suggests a study published ...
May 1, 2024
0
147
New research suggests psilocybin has similar side effects to traditional antidepressants. Commonly referred to as "magic mushrooms," psilocybin is a promising alternative treatment for people with medication-resistant depression ...
Apr 23, 2024
0
99
A recent study suggests that mushroom extract containing psilocybin may exhibit superior efficacy when compared to chemically synthesized psilocybin. The findings are published in the journal Molecular Psychiatry.
Mar 11, 2024
0
82
Rapid-acting antidepressants, including ketamine, scopolamine and psilocybin, have been found to have immediate and lasting positive effects on mood in patients with major depressive disorder but how these effects arise is ...
Jan 10, 2024
0
103
A team of anesthesiologists at the University of Michigan, working with a pair of colleagues from Tryp Therapeutics, has found, via experimentation, that rats can experience a reduction in chronic pain when given injections ...
Results from a Phase II clinical trial indicate that psilocybin, a hallucinogenic chemical found in certain mushrooms of the genus Psilocybe, may benefit individuals with cancer and major depression. Trial participants treated ...
Dec 18, 2023
0
249
